Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Eli Lilly in Podcasts

company

Eli Lilly is a pharmaceutical company involved in drug development and AI collaborations.

Mentions Over Time

20 mentions
6 related entities

Mentions in Podcasts

WSJ What’s News
What’s News in Markets: AI Deals, Trump on Pharma, Banks Split

Pharma stocks Novo Nordisk and Eli Lilly really needed a shot in the arm after comments from President Trump the day before sent their shares falling.

Wall Street Breakfast
IBM to buy Confluent in further AI push

Eli Lilly, Pfizer, and Johnson & Johnson have secured spots on China's first innovative drug catalog for private insurance, a program designed to expand access to high-cost therapies.

Wall Street Breakfast
AI becomes a major e-commerce player

Eli Lilly is up after Learing Partners upgraded shares to Outperform from Market Perform, saying its White House pricing deal could dramatically expand coverage for its obesity drugs.

Morning Brew Daily
Google's AI Leapfrogs its Rivals & Trump-Mamdani Tackle Affordability?

And my winner is Eli Lilly, because on Friday, it became the first healthcare company in the world to reach a market cap of $1 trillion.

Morning Brew Daily
Google's AI Leapfrogs its Rivals & Trump-Mamdani Tackle Affordability?

Today, how a weight loss drug helped Eli Lilly make history.

NPR News Now
NPR News: 12-31-2025 7PM EST

A competing pill made by Eli Lilly could soon follow.

NPR News Now
NPR News: 11-06-2025 11PM EST

Novo Nordisk and Eli Lilly's blockbuster obesity and type 2 diabetes drugs are the centerpiece of agreements announced by the White House.